The tweet was deleted by the author.
But we saved everything 🙂.
CVRx has announced the successful completion of the 25th Barostim implant at UNC Medical Center in Chapel Hill.
The accomplishment recognizes the contributions of Dr. William Tripp Mostertz, nurse practitioners Emily Baker and Sarah Waters, cardiac device technician Keosha McKinney, and the broader medical team. The Barostim device provides innovative therapy options for patients, underscoring the collaboration between clinical experts and device developers in advancing patient care.
CVRx reported a 20 percent increase in total revenue for the first quarter, with U.S. operations rising 22 percent, according to a recent earnings update. The company also began patient enrollment in its BENEFIT-HF clinical trial at North Central Heart, targeting one of the largest studies in cardiac device research. These developments come as CVRx continues to grow its presence in the cardiac device sector.